NC

Nibedita Chakraborty

Active Director Director DIN 01382172
DIN 01382172 First appointment Mar 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Mar 1996
Shareholding value •••• Premium profile

About Nibedita Chakraborty

Data last updated:

Nibedita Chakraborty is a Director at Alteus Biogenics Private Limited (since 2014), Director at Alteus Laboratories Private Limited (since 2020) and Director at Alteus Global Limited (since 2021), and holds 5 more current directorships. The companies operate in Pharma, Financial Services and Automobile. The 5 current companies with reported revenue have a combined latest revenue of ₹237 Cr; the largest is Alteus Biogenics Private Limited at ₹218 Cr (FY 2025).

DIN 01382172
Primary Designation Director
Industry Pharma
First Appointment 01 Mar 1996
Oldest Company Age 34 yrs
Largest company Alteus Biogenics Private Limited · ₹218 Cr (FY 2025)
Combined revenue ₹237 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alteus Biogenics Private Limited U24100WB2008PTC125979
Director01 Jan 20142008₹218 Cr (FY 2025)Active
Alteus Laboratories Private Limited U85190WB2020PTC240408
Director12 Oct 20202020₹12.81 Cr (FY 2022)Active
Alteus Global Limited U24304WB2021PLC249646
Director17 Nov 20212021₹5.80 Cr (FY 2025)Active
Ochre Blue Retail Private Limited U51900WB1991PTC053766
Director06 Nov 20151991₹6 Lakh (FY 2025)Active
Mrittika Production Pvt Ltd U67120WB1996PTC077740
Director01 Mar 19961996₹5.1 Lakh (FY 2025)Active
Alteus Life Limited U21000OD2026PLC052797
Director28 Feb 20262026Active
G99 India Limited U47721WB2024PLC272061
Director15 Jul 20242024Active
G99 Pharmacy Limited U47721WB2024PLC272052
Director12 Jul 20242024Active

Directorship timeline

Open interactive timeline →
G99 India Limited
Alteus Biogenics Private Limited
Alteus Global Limited
Ochre Blue Retail Private Limited
Premium access

Shareholding and investment profile for Nibedita Chakraborty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nibedita Chakraborty

Nibedita Chakraborty currently holds 8 directorships: Alteus Biogenics Private Limited (Director, since 01 Jan 2014, revenue ₹218 Cr (FY 2025)); Alteus Laboratories Private Limited (Director, since 12 Oct 2020, revenue ₹12.81 Cr (FY 2022)); Alteus Global Limited (Director, since 17 Nov 2021, revenue ₹5.80 Cr (FY 2025)); Ochre Blue Retail Private Limited (Director, since 06 Nov 2015, revenue ₹6 Lakh (FY 2025)); Mrittika Production Pvt Ltd (Director, since 01 Mar 1996, revenue ₹5.1 Lakh (FY 2025)); and 3 more.

Nibedita Chakraborty was first appointed on 01 Mar 1996 as Director at Mrittika Production Pvt Ltd. The most recent appointment on record is 28 Feb 2026 at Alteus Life Limited.

The 5 current companies of Nibedita Chakraborty that report revenue have a combined latest revenue of ₹237 Cr: Alteus Biogenics Private Limited ₹218 Cr (FY 2025); Alteus Laboratories Private Limited ₹12.81 Cr (FY 2022); Alteus Global Limited ₹5.80 Cr (FY 2025); Ochre Blue Retail Private Limited ₹6 Lakh (FY 2025); Mrittika Production Pvt Ltd ₹5.1 Lakh (FY 2025).

The current boards of Nibedita Chakraborty's companies include Abesh Mazumder (Alteus Biogenics Private Limited), Debasish Mitra (Alteus Biogenics Private Limited), Reetwija Chakraborty (Alteus Biogenics Private Limited), Soma Dev (Alteus Biogenics Private Limited), Asis Chakraborty (Mrittika Production Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available